BPA Call 36C26021A0063-36C26024N0312
- This federal contract award, valued at $368,963.17, was issued by the Veterans Integrated Service Network 20 (VISN 20) of the U.S. Department of Veterans Affairs (VA) to Abbott Molecular Inc., a subsidiary of Abbott Laboratories. The contract is for the supply of accessories, reagent kits, consumables, and a maintenance agreement for SARS-CoV-2, hepatitis C virus (HCV), human immunodeficiency virus (HIV), and hepatitis B virus (HBV) polymerase chain reaction (PCR) testing. This contract is a...
- This is a firm fixed price Blanket Purchase Agreement (BPA) call award by the Department of Veterans Affairs (VA) Veterans Health Administration to Abbott Molecular Inc., a subsidiary of Abbott Laboratories. The contract has a potential value of $292,136.52 and was made under the Critical Analyzers, Laboratory (FSS-66-III) GSA Schedule. The contract provides HIV molecular diagnostic products and services, including testing consumables and equipment maintenance, to support the VA's clinical...
- This federal contract award was made by the Veterans Integrated Service Network 19 (VISN 19), a civilian agency within the Department of Veterans Affairs (VA), to Abbott Molecular Inc., a subsidiary of Abbott Laboratories. The $1,800,000.00 Blanket Purchase Agreement (BPA) call order is for HIV molecular Clinical Pharmacology Research Resource (CPRR) services. The contract does not have a set-aside designation. The BPA was established under the GSA Schedule 66-III contract for Critical Analyzers...
- This federal contract award to Abbott Molecular Inc., a subsidiary of Abbott Laboratories, is for the provision of accessories, reagent kits, consumables, supplies, and a maintenance agreement for SARS-CoV-2, HCV, HIV, and HBV PCR testing. The contract, valued at $398,718.65, is a Blanket Purchase Agreement (BPA) call with a firm fixed price structure. The contract has an ultimate completion date of July 31, 2026 and was awarded on August 1, 2025. The contracting agency is the Veterans...
- This federal contract award to Abbott Molecular Inc. is for the supply of accessories, reagent kits, consumables, supplies, and a maintenance agreement for SARS-CoV-2, HCV, HIV, and HBV PCR testing. The contract is a Blanket Purchase Agreement (BPA) Call under the General Services Administration (GSA) Schedule 65-VII for In Vitro Diagnostics, Reagents, and Test. The contract has a ceiling value of $296,287.73 and a performance period through July 31, 2022. The contract was awarded on August 1,...
- This is a firm fixed price Blanket Purchase Agreement (BPA) call awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Abbott Molecular Inc., a subsidiary of Abbott Laboratories. The contract has a potential value of $220,046.51 and provides oncology and HIV-1 reagents to the VA. The contract is not set aside for any specific business type. As a large pharmaceutical and medical device manufacturer, Abbott Laboratories has a history of supplying a wide range...
- This federal contract award is a Blanket Purchase Agreement (BPA) issued by the Veterans Integrated Service Network 2 (VISN 2) of the U.S. Department of Veterans Affairs (VA) to Abbott Molecular Inc., a subsidiary of Abbott Laboratories. The BPA is for the provision of molecular testing services, with a ceiling value of $359,131.49. The contract is not set aside for a specific business type. The BPA provides for the delivery of "MOLECULAR TESTING BLANKET PURCHASE AGREEMENT COST PER...
- The Department of Veterans Affairs (VA) awarded a Blanket Purchase Agreement (BPA) call to Abbott Molecular Inc., a subsidiary of Abbott Laboratories, to provide viral load testing services. The contract, valued at up to $307,987.00, is for a firm fixed price and was not set aside for any special business type. The work will be performed in Des Plaines, Illinois and is part of the Critical Analyzers, Laboratory FSS-66-III schedule contract vehicle with the VA's Veterans Health Administration...
- The Department of Veterans Affairs (VA) awarded a Blanket Purchase Agreement (BPA) call to Abbott Molecular Inc., a subsidiary of Abbott Laboratories, for NUCLEIC ACID AND SARS TESTING services. The contract has a ceiling value of $101,904.88 and a period of performance through September 30, 2023. This BPA call was issued under the Critical Analyzers, Laboratory (FSS-66-III) Federal Supply Schedule contract. The award does not have a set-aside designation, as Abbott Molecular is a large...
- This is a contract award to Abbott Molecular Inc., a subsidiary of the pharmaceutical company Abbott Laboratories, by the Department of Veterans Affairs (VA) Veterans Health Administration. The $1,571,827.99 contract is a Blanket Purchase Agreement (BPA) call order under the VA's GSA Schedule 65-VII contract for in vitro diagnostics, reagents, and tests. The contract is for the supply of COVID-19 testing equipment and molecular analyzers to the VA, without the need for sample aliquoting. This...
- Invitro Diagnostics, Reagents, Test (FSS-65-VII)Master GSA Schedule
- V797D40222-36C26021A0063Blanket Purchase Agreement
- 36C26021A0063-36C26024N0312BPA Call
This is a $398,718.65 Firm Fixed Price Blanket Purchase Agreement (BPA) Call contract awarded by the Veterans Integrated Service Network 20 (VISN 20) of the U.S. Department of Veterans Affairs (VA) to Abbott Molecular Inc., a subsidiary of Abbott Laboratories. The contract is for the supply of accessories, reagent kits, consumables, supplies, and a maintenance agreement for SARS-CoV-2, HCV, HIV, and HBV PCR testing. This contract is not set aside for any specific business size or socioeconomic category. The ultimate completion date is July 31, 2025. Abbott Molecular Inc. is an experienced provider of molecular diagnostics equipment, reagents, and testing services to federal agencies including the VA, Centers for Disease Control and Prevention, and Department of the Army. The parent company, Abbott Laboratories, is a global healthcare company that has received numerous awards from the VA and Department of Health and Human Services for a range of medical devices, diagnostic products, and nutritional supplements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $398.7k | 7/2/24 |